Intellectual Property India Publishes Patent Application for 'Exatecan Derivatives And Antibody-Drug Conjugates Thereof' Filed by Alx Oncology Inc.

MUMBAI, India, June 13 -- Intellectual Property India has published a patent application (202517051779 A) filed by Alx Oncology Inc., San Francisco, on May 29, for 'exatecan derivatives and antibody-drug conjugates thereof.'

Inventor(s) include Pons, Jaume; Vrljic, Marija; Strop, Peter; Wong, Janica Cheuk-Ying; and Daino-Laizure, Hanako.

The application for the patent was published on June 13, under issue no. 24/2025.

According to the abstract released by the Intellectual Property India: "Disclosed herein, in part, are novel exatecan derivatives with novel chemical linkers that include cathepsin B cleavable moieties and conjugated to targeting antibodies. In a preferred embodiment the antibody is an anti-TROP2, an anti-EGFR or an anti-HE...